Clinical Trial

Glycocalyx and Oxidative Stress in Endothelial Function (Part 1)

Study acronym: GlikoOxEND
Recruiting
View on ClinicalTrials.gov →
Summary
The primary research objective of the project is to determine the role of eGC in microvascular reactivity in CKD (cross-sectional study 1). The main objective of the project is to increase the excellence and interdisciplinarity of scientific work at MEFOS by connecting researchers from different scientific fields, improving conditions and resources for scientific work, and increasing international cooperation, in line with strategic objective 1: raising scientific excellence. The results of the project could provide pathophysiological insight into the development and maintenance of endothelial dysfunction in CKD, as well as identify new biomarkers for CKD.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-24.
Trial Details
NCT Number NCT07437729
Lead Sponsor Josip Juraj Strossmayer University of Osijek
Conditions Chronic Kidney Disease Patients
Enrollment 105 participants
Start Date 2025-10-01
Primary Completion 2029-09-30 (estimated)
Study Completion 2029-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-02